These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia. Spazierer D; Fuchs P; Reipert S; Fischer I; Schmuth M; Lassmann H; Wiche G Mol Cell Biol; 2006 Jan; 26(2):559-68. PubMed ID: 16382147 [TBL] [Abstract][Full Text] [Related]
4. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. Wögenstein KL; Szabo S; Lunova M; Wiche G; Haybaeck J; Strnad P; Boor P; Wagner M; Fuchs P PLoS One; 2014; 9(9):e108323. PubMed ID: 25232867 [TBL] [Abstract][Full Text] [Related]
5. Stress-induced recruitment of epiplakin to keratin networks increases their resistance to hyperphosphorylation-induced disruption. Spazierer D; Raberger J; Gross K; Fuchs P; Wiche G J Cell Sci; 2008 Mar; 121(Pt 6):825-33. PubMed ID: 18285451 [TBL] [Abstract][Full Text] [Related]
6. Characterization of human epiplakin: RNAi-mediated epiplakin depletion leads to the disruption of keratin and vimentin IF networks. Jang SI; Kalinin A; Takahashi K; Marekov LN; Steinert PM J Cell Sci; 2005 Feb; 118(Pt 4):781-93. PubMed ID: 15671067 [TBL] [Abstract][Full Text] [Related]
7. Epiplakin accelerates the lateral organization of keratin filaments during wound healing. Ishikawa K; Sumiyoshi H; Matsuo N; Takeo N; Goto M; Okamoto O; Tatsukawa S; Kitamura H; Fujikura Y; Yoshioka H; Fujiwara S J Dermatol Sci; 2010 Nov; 60(2):95-104. PubMed ID: 20926261 [TBL] [Abstract][Full Text] [Related]
8. Interactions between epiplakin and intermediate filaments. Wang W; Sumiyoshi H; Yoshioka H; Fujiwara S J Dermatol; 2006 Aug; 33(8):518-27. PubMed ID: 16923132 [TBL] [Abstract][Full Text] [Related]
9. Effects of epiplakin-knockdown in cultured corneal epithelial cells. Kokado M; Okada Y; Miyamoto T; Yamanaka O; Saika S BMC Res Notes; 2016 May; 9():278. PubMed ID: 27206504 [TBL] [Abstract][Full Text] [Related]
10. A Ca Ratajczyk S; Drexler C; Windoffer R; Leube RE; Fuchs P Cells; 2022 Sep; 11(19):. PubMed ID: 36231039 [TBL] [Abstract][Full Text] [Related]
11. Epiplakin gene analysis in mouse reveals a single exon encoding a 725-kDa protein with expression restricted to epithelial tissues. Spazierer D; Fuchs P; Pröll V; Janda L; Oehler S; Fischer I; Hauptmann R; Wiche G J Biol Chem; 2003 Aug; 278(34):31657-66. PubMed ID: 12791695 [TBL] [Abstract][Full Text] [Related]
12. Elimination of epiplakin by gene targeting results in acceleration of keratinocyte migration in mice. Goto M; Sumiyoshi H; Sakai T; Fässler R; Ohashi S; Adachi E; Yoshioka H; Fujiwara S Mol Cell Biol; 2006 Jan; 26(2):548-58. PubMed ID: 16382146 [TBL] [Abstract][Full Text] [Related]
13. Epiplakin, a novel member of the Plakin family originally identified as a 450-kDa human epidermal autoantigen. Structure and tissue localization. Fujiwara S; Takeo N; Otani Y; Parry DA; Kunimatsu M; Lu R; Sasaki M; Matsuo N; Khaleduzzaman M; Yoshioka H J Biol Chem; 2001 Apr; 276(16):13340-7. PubMed ID: 11278896 [TBL] [Abstract][Full Text] [Related]
14. Increased fragility, impaired differentiation, and acceleration of migration of corneal epithelium of epiplakin-null mice. Kokado M; Okada Y; Goto M; Ishikawa K; Miyamoto T; Yamanaka O; Fujiwara S; Saika S Invest Ophthalmol Vis Sci; 2013 May; 54(5):3780-9. PubMed ID: 23599337 [TBL] [Abstract][Full Text] [Related]